Difficult intubations have long posed serious risks during airway management, often lacking practical solutions. SharpMed, LLC has developed a patented innovation—the Turbo® O₂ Cap—which seamlessly attaches to any standard endotracheal tube used worldwide. This device is designed to maintain oxygenation during challenging intubation scenarios.
Controlled studies comparing the Turbo® O₂ Cap to traditional techniques (without the device) demonstrated significantly improved oxygen saturation levels. Notably, both study groups involved complete muscular paralysis, closely mimicking real-world difficult intubation conditions.
“These results point to the first practical, affordable device capable of enhancing patient safety during intubations. We envision the Turbo® O₂ Cap becoming a new standard of care,” said Chris Salvino, MD, CEO of SharpMed. The company is currently advancing the commercialization process for the device.